-
Digoxin has no association with mortality in patients with heart failure in the AFFIRM study when bias is removed with a careful propensity-matched analysis.
-
Once-daily Tadalafil for ED: Efficacy and Safety; Psychological Disorders: How to Give Patients What They Want and What They Need; Reducing Stroke Risk After TIA or Minor Ischemic Stroke
-
A brief web intervention improved shared decision making regarding prostate cancer screening.
-
It is critical to address contraception at each interconception visit with women with prior gestational diabetes mellitus (GDM).
-
Vaccination for human papillomavirus (HPV) rates in US girls ages 13-17 failed to increase between 2011 and 2012.
-
Enrollment for a 3,200-subject Phase III registration study has been completed for Amphora, a non-hormonal contraceptive gel.
-
Providers might need to seek other long-acting reversible contraceptive methods other than the new smaller levonorgestrel intrauterine device, Skyla.
-
Long-acting reversible contraceptives (LARCs), such as intrauterine devices (IUDs) and the contraceptive implant, can help young women achieve their goals.
-
-
Results of a trial conducted by the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health indicate two new antibiotic regimens.